ChitogenX Inc.
CHGX
Peringkat dalam Saham
#39856
ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and... ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and sports medicine. The company is dedicated to the research and development of innovative therapeutic technologies designed to improve the success rates of soft tissue repair in sports medicine surgeries. Its product pipeline features several biomaterial-based treatments, including Ortho-R for rotator cuff repair, Ortho-M for meniscus repair, and Ortho-C for articular cartilage repair. Additionally, they are developing Ortho-V to address osteoarthritis healing and ORTHO-T for tendon regeneration. Established in 2015, the company underwent a name change from Ortho Regenerative Technologies Inc. to ChitogenX Inc. in September 2022. It maintains its headquarters in Kirkland, Canada.
Harga Saham
$0.00365786
Terakhir disinkronkan: 2025-07-07
Kapitalisasi Pasar
$293.82K
Perubahan (1 hari)
-0.43%
Perubahan (1 tahun)
-28.28%
Negara
CA
Perdagangan ChitogenX Inc. (CHGX)
Kategori
Healthcare
Riwayat harga saham ChitogenX Inc. (CHGX)
Harga penutupan tertinggi: $0.01 pada 2026-10-01
Harga penutupan terendah: $0.46 pada 2020-10-01
Harga penutupan terendah: $0.46 pada 2020-10-01
Riwayat harga saham ChitogenX Inc. dari 2020 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | -53.93% |
| 2024 | -85.54% |
| 2023 | -64.19% |
| 2022 | -43.64% |
| 2021 | -43.08% |
| 2020 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $525.12 | 23.14% |
US
|
|
| $237.61 | 784.95% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $887.75 | 9.04% |
NL
|
|
| $289.96 | 1.88% |
BE
|
